Bate, Fanucci Up, Kailian Out in Millennium s Management Musical Chairs; Don Westmacott and Manzur Durrani Join Quark Biotech; and Others | GenomeWeb

NEW YORK, July 16 - Don Westmacott has been appointed director of bioassay development and high-throughput screening, and Manzer Durrani has been appointed vice president of pharmaceutics and manufacturing at the new Fremont, Calif., facility of Quark Biotech, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.